Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 3
1986 6
1987 1
1988 1
1990 2
1991 3
1994 1
1995 4
1996 2
1997 1
1999 1
2002 2
2007 1
2008 7
2009 3
2010 1
2011 2
2012 1
2015 3
2016 5
2017 4
2018 3
2019 1
2020 3
2022 3
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M; MONALISA study group. Charlier C, et al. Lancet Infect Dis. 2017 May;17(5):510-519. doi: 10.1016/S1473-3099(16)30521-7. Epub 2017 Jan 28. Lancet Infect Dis. 2017. PMID: 28139432 Free article.
[POEMS syndrome].
Pruvost E, Gatfossé M, Calzada MC, Mekinian A, Fain O. Pruvost E, et al. Among authors: gatfosse m. Rev Prat. 2015 May;65(5):606. Rev Prat. 2015. PMID: 26165089 French. No abstract available.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
[Sweet syndrome].
Hefez L, Gatfossé M, Mekinian A, Fain O. Hefez L, et al. Among authors: gatfosse m. Rev Prat. 2017 Apr;67(4):399. Rev Prat. 2017. PMID: 30525337 French. No abstract available.
[Insulin edema in hepatic glycogenosis].
Mahévas T, Gobert D, Gatfossé M, Mekinian A, Fain O. Mahévas T, et al. Among authors: gatfosse m. Rev Med Interne. 2017 Mar;38(3):201-203. doi: 10.1016/j.revmed.2016.05.001. Epub 2016 Oct 13. Rev Med Interne. 2017. PMID: 27745935 French.
Overview of osteo-articular involvement in systemic sclerosis: Specific risk factors, clinico-sonographic evaluation, and comparison with healthy women from the French OFELY cohort.
Thietart S, Louati K, Gatfosse M, Sornay-Rendu E, Gaigneux E, Lemeunier L, Delmaire P, Riviere S, Mahevas T, Sellam J, Berenbaum F, Fain O, Roland C, Mekinian A. Thietart S, et al. Among authors: gatfosse m. Best Pract Res Clin Rheumatol. 2018 Aug;32(4):591-604. doi: 10.1016/j.berh.2019.01.008. Epub 2019 Feb 20. Best Pract Res Clin Rheumatol. 2018. PMID: 31174827 Review.
[A glioblastoma reveals tuberous sclerosis complex].
Zuelgaray E, Gobert D, Gatfosse M, Guegan S, Fain O. Zuelgaray E, et al. Among authors: gatfosse m. Presse Med. 2016 Jun;45(6 Pt 1):595-7. doi: 10.1016/j.lpm.2015.11.009. Epub 2016 Mar 19. Presse Med. 2016. PMID: 27006246 French. No abstract available.
[Henoch-Schoenlein purpura].
Laurent C, Mekinian A, Viry F, Gatfossé M, Fain O. Laurent C, et al. Among authors: gatfosse m. Rev Prat. 2016 Jan;66(1):53. Rev Prat. 2016. PMID: 30512401 French. No abstract available.
[Shulman syndrome].
Sitbon C, Gobert D, Gatfossé M, Mekinian A, Fain O. Sitbon C, et al. Among authors: gatfosse m. Rev Prat. 2015 Mar;65(3):312. Rev Prat. 2015. PMID: 26016182 French. No abstract available.
Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves' Orbitopathy.
Bennedjaï A, Bouheraoua N, Gatfossé M, Dupasquier-Fediaevsky L, Errera MH, Tazartes M, Borderie V, Hennocq Q, Dellal A, Riviere S, Heron E, Fain O, Mekinian A. Bennedjaï A, et al. Among authors: gatfosse m. Ocul Immunol Inflamm. 2022 Feb 17;30(2):500-505. doi: 10.1080/09273948.2020.1808688. Epub 2020 Sep 23. Ocul Immunol Inflamm. 2022. PMID: 32965148
61 results